Difficulty: Medium
Average Score: 67%
Testbank
A nurse on a medical-surgical unit is planning to administer an antibiotic to a patient with a kidney infection who is 10 weeks' pregnant. The drug reference states that the medication is teratogenic. Which action will the nurse take?
Correct answer
B
Rationale
Hold the medication and collaborate with the health care provider to find an alternative. This action prioritizes the safety of the pregnant patient and the developing fetus, as administering a teratogenic antibiotic could pose significant risks during the critical first trimester of pregnancy. Collaborating with the healthcare provider allows for a thorough assessment and selection of a safer treatment option.
A: Administer the medication, because the risk of illness is greater than the benefit of the medication. This option disregards the potential harm to the developing fetus, which is a crucial consideration in managing medication during pregnancy.
C: Ask the patient if they consent to receive the medication and document the response in the electronic health record. Seeking consent does not address the ethical responsibility to avoid administering a teratogenic drug, especially when safer alternatives may be available.
D: Collaborate with the pharmacist on dose reduction. While dose reduction can be important for some medications, it does not resolve the fundamental issue of teratogenicity, which could still harm the fetus even at lower doses.
A: Administer the medication, because the risk of illness is greater than the benefit of the medication. This option disregards the potential harm to the developing fetus, which is a crucial consideration in managing medication during pregnancy.
C: Ask the patient if they consent to receive the medication and document the response in the electronic health record. Seeking consent does not address the ethical responsibility to avoid administering a teratogenic drug, especially when safer alternatives may be available.
D: Collaborate with the pharmacist on dose reduction. While dose reduction can be important for some medications, it does not resolve the fundamental issue of teratogenicity, which could still harm the fetus even at lower doses.